ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 126 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 0.52 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,480,000 | -77.3% | 237,566 | -85.8% | 0.04% | -78.4% |
| Q2 2019 | $19,724,000 | +3312.5% | 1,675,804 | +3856.1% | 0.16% | +5300.0% |
| Q1 2019 | $578,000 | -51.6% | 42,360 | -26.2% | 0.00% | -62.5% |
| Q4 2016 | $1,195,000 | -93.1% | 57,421 | -89.1% | 0.01% | -93.5% |
| Q3 2016 | $17,242,000 | -26.9% | 526,142 | -44.3% | 0.12% | -37.9% |
| Q2 2016 | $23,583,000 | +450.2% | 944,459 | +439.6% | 0.20% | +382.9% |
| Q1 2016 | $4,286,000 | +21.0% | 175,020 | +61.9% | 0.04% | -6.8% |
| Q3 2015 | $3,541,000 | – | 108,105 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 229,895 | $7,593,000 | 6.73% |
| Foresite Capital Management II, LLC | 419,997 | $13,873,000 | 4.65% |
| Cormorant Asset Management, LP | 757,475 | $25,019,000 | 2.99% |
| NEXTHERA CAPITAL LP | 60,000 | $1,982,000 | 2.81% |
| SENZAR ASSET MANAGEMENT, LLC | 557,170 | $18,403,325,000 | 2.05% |
| Parametrica Management Ltd | 9,360 | $309,000 | 2.04% |
| Partner Investment Management, L.P. | 36,756 | $1,214,000 | 1.99% |
| PFM Health Sciences, LP | 1,890,030 | $62,428,000 | 1.90% |
| PYRRHO CAPITAL MANAGEMENT, LP | 63,000 | $2,081,000 | 1.40% |
| BB BIOTECH AG | 1,510,150 | $49,880,000 | 1.40% |